Home/Recalls/FDA-Z-2513-2026
FDA DevicesClass II

iLet Bionic Pancreas, REF: BB1001

Published: June 24, 2026Recall ID: Z-2513-2026Category: devicesCountry: US

Reason for Recall / Hazard

The reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.

Product Description & Identification

iLet Bionic Pancreas, REF: BB1001

Additional Source Details

FieldValue
CityIrvine
StateCA
Event id98517
Address 111 Hughes
Code infoiLet ACE Pump firmware BOM000072 Rev C (version 3.3.6) and BOM000072 Rev B (version 3.3.4)
Postal code92618-1902
Report date20260624
Product typeDevices
Product quantity4580
Reason for recallThe reason for the recall is: it was found in version 3.3.6 of the iLet ACE Pump firmware and all previous releases that a screen unlock failure could occur when the user successfully slides the unlock slider on the Lock Screen, no screen transition occurs, and the user remains on the Lock Screen. Because the user cannot exit the Lock Screen, the user is unable to perform a cartridge change or meal announcement. If this occurs and therapy is in progress, therapy will continue normally until the insulin cartridge is depleted. The user will be unable to perform a cartridge change or a meal announcement and will be stuck on the screen until the battery fully drains. This can lead to hyperglycemia.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20250923
Initial firm notificationLetter
Center classification date20260618

Overview

  • Recalling FirmBeta Bionics, Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS: WI, HI, OH, ME, CO, NJ, NE, KY, SC, CA, TX, NH, NY, WA, PA, MD, FL, IA, GA, MI, VT, TN, IL, IN, KS, MA, LA, MS, NC, CT, MN, VA, OK, AR, AZ, MO, MT, RI, DC, NM, OR, ID, NV, AK, ND, DE, WV, WY, SD, UT, AL
Official Agency Alert